PHASEBIO PHARMACEUTICALS INC

Profile

Company Names

PHASEBIO PHARMACEUTICALS INC

Addresses

ONE GREAT VALLEY PARKWAY, SUITE30, MALVERN, PA 19355

ONE GREAT VALLEY PARKWAY, SUITE 30, MALVERN, PA 19355

1 GREAT VALLEY PARKWAY, SUITE 30, MALVERN, PA 19355

4020 AERIAL CENTER PARKWAY, SUITE 101, MORRISVILLE, NC 27560

Phone Numbers

(610) 981-6500
610-981-6500
610-608-8563
919-535-8861

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$103,137,196.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-08-27 
$25,998,130.00 
$32,125,000.00 
$6,126,870.00 
Equity 
4
2017-01-17 
$6,615,000.00 
$7,875,000.00 
$1,260,000.00 
Debt 
3
2015-02-26 
$21,000,000.00 
$42,000,000.00 
$21,000,000.00 
Equity 
2
2009-12-22 
$48,524,067.00 
$48,524,067.00 
$0.00 
Equity 
1
2009-11-03 
$999,999.00 
$1,000,000.00 
$1.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
BARRETT 
DIRECTOR
PREDICTIVE BIOSCIENCES, INC   |  CARDIOXYL PHARMACEUTICALS INC   |  PHASEBIO PHARMACEUTICALS INC   |  AMICUS THERAPEUTICS INC   |  HOMETOWN FINANCIAL GROUP INC   |  BLEND BIOSCIENCES, INC.   |  BLEND THERAPEUTICS, INC.   |  AGENEBIO, INC.   |  ZP HOLDINGS INC   |  LOXO ONCOLOGY, INC.   |  NEXIMMUNE, INC.   |  GALERA THERAPEUTICS, INC.   |  TARVEDA THERAPEUTICS, INC.   |  EDGE TOTAL INTELLIGENCE INC.   |  ABSURD SNACKS - LIGHTHOUSE NETWORK VENTURES, LLC
ASHUTOSH 
 
CHILKOTI 
DIRECTOR, EXECUTIVE OFFICER
PHASEBIO PHARMACEUTICALS INC   |  INSOMA BIO, INC.
GUY 
 
FISH 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  METABOLON, INC   |  ARCH THERAPEUTICS, INC.
MICHAEL 
 
GUTCH 
DIRECTOR
G1 THERAPEUTICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  ENTASIS THERAPEUTICS HOLDINGS INC.
NANCY 
 
HUTSON 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC
ROBERT 
 
INGRAM 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  VIRGINIA ENERGY RESOURCES INC   |  GOLDEN BAND RESOURCES INC.   |  VIAMET PHARMACEUTICALS HOLDINGS LLC
JUSTIN 
 
KLEIN 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  ULTHERA INC   |  CV INGENUITY CORP.   |  ADVANCED CARDIAC THERAPEUTICS INC   |  VYTRONUS INC   |  CARTIVA, INC.   |  RELIEVANT MEDSYSTEMS INC   |  INTACT VASCULAR, INC.   |  PERSONAL GENOME DIAGNOSTICS INC.   |  VESPER MEDICAL, INC.   |  CHROMACODE, INC.   |  RELIEVANT MEDSYSTEMS, INC.   |  LUNA HEALTH, INC.   |  VENTARIS SURGICAL, INC.
THOMAS 
K 
LAUNDON 
EXECUTIVE OFFICER, DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  G-ZERO THERAPEUTICS, INC.   |  G1 THERAPEUTICS, INC.
CAROLINE 
 
LOEWY 
DIRECTOR
CORCEPT THERAPEUTICS INC   |  PHASEBIO PHARMACEUTICALS INC
JONATHAN 
 
MOW 
EXECUTIVE OFFICER, DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  VERALOX THERAPEUTICS INC.   |  TREFOIL THERAPEUTICS, INC.
BIBHASH 
 
MUKHOPADHYAY 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  NEPHRODI THERAPEUTICS, INC.
CHRISTOPHER 
 
PRIOR 
EXECUTIVE OFFICER, DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  INNOVATE BIOPHARMACEUTICALS, INC.   |  IB PHARMACEUTICALS INC.
DOUGLAS 
 
REED 
DIRECTOR
SPINEWORKS MEDICAL INC   |  SPINEALIGN MEDICAL INC   |  VIAMET PHARMACEUTICALS INC   |  PHASEBIO PHARMACEUTICALS INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  HATTERAS VENTURE PARTNERS IV, LP   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  NEUROTRONIK, INC.   |  SIDERIS PHARMACEUTICALS, INC.   |  COFERON, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  BLINKBIO, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  QPEX BIOPHARMA, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  EMX ROYALTY CORP   |  AVIVOMED INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC
TYRELL 
 
RIVERS 
DIRECTOR
VIELA BIO, INC.   |  CORVIDIA THERAPEUTICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  CERAPEDICS INC   |  NUCLEUS RADIOPHARMA, INC.   |  PATHOS AI, INC.
CRAIG 
 
ROSEN 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  EPIRUS, INC.
JOHN 
 
SHARP 
EXECUTIVE OFFICER
HUYA BIOSCIENCE INTERNATIONAL, LLC   |  PHASEBIO PHARMACEUTICALS INC   |  ETX ENERGY, LLC
WILL 
 
SHEN 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC
JOEL 
 
SUSSMAN 
EXECUTIVE OFFICER
ASCENTA THERAPEUTICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  GALERA THERAPEUTICS, INC.   |  IMMUNOME INC.
CLAY 
 
THORP 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC   |  CANCERGUIDE DIAGNOSTICS, INC.   |  PATHFINDER THERAPEUTICS, INC.   |  CLEARSIDE BIOMEDICAL, INC.   |  G-ZERO THERAPEUTICS, INC.   |  GENECENTRIC DIAGNOSTICS, INC.   |  G1 THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  ORIG3N, INC.   |  STRIDEBIO, INC.   |  GENECENTRIC THERAPEUTICS, INC.   |  VIGIL NEUROSCIENCE, INC.   |  PIPR THERAPEUTICS, INC.
LINDA 
 
TUFTS 
DIRECTOR
SIRONRX THERAPEUTICS, INC.   |  JUVENTAS THERAPEUTICS INC   |  HISTOSONICS, INC.   |  PHASEBIO PHARMACEUTICALS INC   |  SWIFT BIOSCIENCES, INC.
ASISH 
K 
XAVIER 
DIRECTOR
PHASEBIO PHARMACEUTICALS INC
ASISH 
K. 
XAVIER 
DIRECTOR
PROTAGONIST THERAPEUTICS INC   |  VIACYTE INC.   |  PHASEBIO PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-09-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-27 
2017-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-01-17 
2015-07-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-26 
2015-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-26 
2012-06-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-22 
2010-12-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-22 
2010-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-12-22 
2009-11-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#